1. Home
  2. REPL vs VTOL Comparison

REPL vs VTOL Comparison

Compare REPL & VTOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

N/A

Current Price

$22.28

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Bristow Group Inc.

VTOL

Bristow Group Inc.

N/A

Current Price

$38.23

Market Cap

1.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
REPL
VTOL
Founded
2015
1948
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
REPL
VTOL
Price
$22.28
$38.23
Analyst Decision
Buy
Strong Buy
Analyst Count
8
3
Target Price
$23.33
★ $64.33
AVG Volume (30 Days)
★ 3.0M
230.1K
Earning Date
10-28-2026
11-03-2026
Dividend Yield
N/A
★ 1.34%
EPS Growth
N/A
★ 34.58
EPS
N/A
★ 2.07
Revenue
N/A
★ $1,490,512,000.00
Revenue This Year
N/A
$12.18
Revenue Next Year
$513.15
$5.94
P/E Ratio
★ N/A
$18.11
Revenue Growth
N/A
★ 5.30
52 Week Low
$1.50
$35.65
52 Week High
$21.91
$50.38

Technical Indicators

Market Signals
Indicator
REPL
VTOL
Relative Strength Index (RSI) 81.09 41.07
Support Level $7.11 $37.17
Resistance Level N/A $43.39
Average True Range (ATR) 1.43 1.71
MACD 0.90 -0.20
Stochastic Oscillator 96.10 33.49

Price Performance

Historical Comparison
REPL
VTOL

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

About VTOL Bristow Group Inc.

Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers are in the UK, Norway, the USA, Nigeria, and Others. The offshore energy customers use services to transport personnel to, from and between offshore energy installations. The majority of revenue is generated from Offshore Energy Services.

Share on Social Networks: